Study to Evaluate the Digestive Tolerability of ART44 Versus ART®50 in Patients With Osteoarthritis of the Knee
NCT01009671
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
210
Enrollment
INDUSTRY
Sponsor class
Conditions
Knee Osteoarthritis
Interventions
DRUG:
ART 44
DRUG:
ART 50
Sponsor
Laboratoires NEGMA